The success and failure of BCG — implications for a novel tuberculosis vaccine

By P. Andersen, T. Doherty. Nature Reviews Microbiology, 2005

810 citations recorded by the source corpus.

Subfields: Immunology, Infectious Diseases

View Paper: https://www.semanticscholar.org/paper/22df6fd4c57f2888e03e02acafb168f07914adff

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Immunology

1. A. O’Garra

In Infectious Diseases

1. A. O’Garra
2. R. Wilkinson
3. M. Berry
4. Finlay W Mcnab
5. Paul S. Redford
6. C. Bloom

Citations in the corpus

• Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved (2010, neutral): “bovis , offers no protection against pulmonary tuberculosis in adult”
• The immune response in tuberculosis. (2013, background): “Thus, falsepositive TST reactions can occur both in those who have been vaccinated, which accounts for more than 3 billion people worldwide (55), and in those who have been sensitized to these common antigens through exposure to environmental nontuberculous mycobacteria (56, 57).”
• Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials. (2014, positive): “offering protection when infection precedes vaccination [37].”